Henriett Butz (H Butz)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Neuroendocrine Tumors

Endoplasmic Reticulum

Gene Expression

Top Venues

International journal of molecular sciences

The Journal of clinical endocrinology and metabolism

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Attila Patocs, Petra Nagy, János Papp, Anikó Bozsik, Bálint Antal, Vince Kornél Grolmusz, Tímea Pócza, Henriett Butz
Cost-effectiveness of genetic testing of endocrine tumor patients using a comprehensive hereditary cancer gene panel. The Journal of clinical endocrinology and metabolism (2024)
Henriett Butz, Attila Patócs, Péter Igaz
Circulating non-coding RNA biomarkers of endocrine tumours. Nature reviews. Endocrinology (2024)
Henriett Butz, Anikó Bozsik, Vince Grolmusz, Erika Szőcs, János Papp, Attila Patócs
Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre. Scientific reports 13 (1) (2023)
Henriett Butz, Attila Patócs
Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. Cancer metastasis reviews (2022)
Barbara Mátyási, Gábor Petővári, Titanilla Dankó, Henriett Butz, Istvan Liko, Péter Lőw, Isabelle Petit, Randa Bittar, Dominique Bonnefont-Rousselot, Zsolt Farkas, Tamás Szeniczey, Kinga Molnár, Krisztina Pálóczi, Edit Irén Buzás, Mathieu Boissan, Anna Sebestyén, Krisztina Takács-Vellai
Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts. Cancers 14 (16) (2022)
Balazs Sarkadi, Éva Saskői, Henriett Butz, Attila Patocs
Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach. International journal of molecular sciences 23 (3) (2022)
Borbála Szabó, Kinga Németh, Katalin Mészáros, Lilla Krokker, István Likó, Éva Saskői, Krisztina Németh, Pál Tamás Szabó, Nikolette Szücs, Sándor Czirják, Gábor Szalóki, Attila Patócs, Henriett Butz
Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma. The Journal of clinical endocrinology and metabolism 107 (11) (2022)
Henriett Butz
Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin. International journal of molecular sciences 23 (9) (2022)
Péter István Turai, Gábor Nyírő, Henriett Butz, Attila Patócs, Péter Igaz
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma. Cancers 13 (7) (2021)
Henriett Butz, Katalin Mészáros, Istvan Liko, Attila Patocs
Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs. International journal of molecular sciences 22 (21) (2021)
Lilla Krokker, Attila Patócs, Henriett Butz
Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors. Genes 12 (5) (2021)
Balazs Sarkadi, Istvan Liko, Gabor Nyiro, Péter Igaz, Henriett Butz, Attila Patocs
Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma. Cancers 13 (16) (2021)
Henriett Butz, János Papp, Anikó Bozsik, Lilla Krokker, Tímea Pócza, Edit Oláh, Attila Patócs
Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants. Cancers 13 (4) (2021)
K Németh, O Darvasi, I Likó, N Szücs, S Czirják, L Reiniger, B Szabó, P A Kurucz, L Krokker, P Igaz, A Patócs, Henriett Butz
Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas. Journal of endocrinological investigation 42 (8) (2019)
Lilla Krokker, Gábor Nyírő, Lilla Reiniger, Ottó Darvasi, Nikolette Szücs, Sándor Czirják, Miklós Tóth, Péter Igaz, Attila Patócs, Henriett Butz
Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma. Neurochemical research 44 (10) (2019)
O Darvasi, P M Szabo, K Nemeth, K Szabo, S Spisak, I Liko, S Czirjak, K Racz, P Igaz, A Patocs, Henriett Butz
Limitations of high throughput methods for miRNA expression profiles in non-functioning pituitary adenomas. Pathology oncology research : POR 25 (1) (2017)